Pharmacokinetics of isoniazid, rifampicin, pyrazinamide and ethambutol in Indian children

被引：0
|
作者：
Aparna Mukherjee
Thirumurthy Velpandian
Mohit Singla
Kunwar Kanhiya
Sushil K Kabra
Rakesh Lodha
机构：
[1] All India Institute of Medical Sciences,Department of Pediatrics
[2] All India Institute of Medical Sciences,Department of Ocular Pharmacology
来源：
BMC Infectious Diseases | / 15卷
关键词：
Tuberculosis; Children; Plasma concentrations; Anti-tubercular therapy; Malnutrition;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Pharmacokinetics of isoniazid, rifampicin, pyrazinamide and ethambutol in Indian children
    Mukherjee, Aparna
    Velpandian, Thirumurthy
    Singla, Mohit
    Kanhiya, Kunwar
    Kabra, Sushil K.
    Lodha, Rakesh
    BMC INFECTIOUS DISEASES, 2015, 15
  • [2] Pharmacokinetics of isoniazid, rifampicin, pyrazinamide and ethambutol in HIV-infected Indian children
    Mukherjee, A.
    Velpandian, T.
    Singla, M.
    Kanhiya, K.
    Kabra, S. K.
    Lodha, R.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2016, 20 (05) : 666 - 672
  • [3] Ethambutol/isoniazid/pyrazinamide/rifampicinSarcoidosis (first report for ethambutol, pyrazinamide and rifampicin): case report
    Reactions Weekly, 2012, 1406 (1) : 21 - 21
  • [4] Population pharmacokinetics, optimised design and sample size determination for rifampicin, isoniazid, ethambutol and pyrazinamide in the mouse
    Chen, Chunli
    Ortega, Fatima
    Alameda, Laura
    Ferrer, Santiago
    Simonsson, Ulrika S. H.
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2016, 93 : 319 - 333
  • [5] Bioequivalence assessment of rifampicin, isoniazid and pyrazinamide in a fixed dose combination of rifampicin, isoniazid, pyrazinamide and ethambutol vs. separate formulations
    Agrawal, S
    Singh, I
    Kaur, KJ
    Bhade, SR
    Kaul, CL
    Panchagnula, R
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2002, 40 (10) : 474 - 481
  • [6] The effect of rifampicin and pyrazinamide on isoniazid pharmacokinetics in rats
    Baldan, Helen M.
    De Rosa, Helene J.
    Brunetti, Iguatemy L.
    Ximenes, Valdecir F.
    Machado, Rosangela G. P.
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2007, 28 (08) : 409 - 413
  • [7] Rifampicin/isoniazid/pyrazinamide/ethambutol and Isoniazid/rifampicinDrug resistance in rifampicin-susceptible pulmonary tuberculosis : 2 case reports
    Reactions Weekly, 2017, 1678 (1) : 155 - 155
  • [8] Rifampicin/isoniazid/pyrazinamide/ethambutol/pyridoxineStevens-Johnson syndrome: case report
    Reactions Weekly, 2021, 1884 (1) : 375 - 375
  • [9] Rifampicin/isoniazid/pyrazinamide/ethambutol/ethambutolDRESS syndrome and pruritic rash: case report
    Reactions Weekly, 2022, 1936 (1) : 429 - 429
  • [10] Pharmacokinetics and safety/tolerability of isoniazid, rifampicin and pyrazinamide in children and adolescents treated for tuberculous meningitis
    Ruslami, Rovina
    Gafar, Fajri
    Yunivita, Vycke
    Parwati, Ida
    Ganiem, Ahmad R.
    Aarnoutse, Rob E.
    Wilffert, Bob
    Alffenaar, Jan-Willem C.
    Nataprawira, Heda M.
    ARCHIVES OF DISEASE IN CHILDHOOD, 2022, 107 (01) : 70 - 77
12345